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1. Introduction 
The human basal ganglia constitutes a functional neural network located at the base of the 
forebrain. It receives most of its afferent inputs through the striatum, the major nucleus of 
the basal ganglia accomplishing fast neurotransmitter-mediated operations through 
somatotopically organized projections to the principal neuron cell type, the striatal 
GABAergic spiny projection neurons. This spiny projection neurons, which make up 95 % of 
the neuron population of striatum (Kemp & Powell 1971), receive excitatory glutamatergic 
inputs from all areas of the cortex and specific thalamic nuclei (Gerfen & Wilson 1996; Bolam 
et al., 2000; Voorn et al., 2004; Doig et al., 2010), and also modulatory dopaminergic inputs 
from the substantia nigra pars compacta (Smith & Kieval 2000; Utter. & Basso 2008). Spiny 
Projection Neurons include two major subpopulations giving rise to the direct striato-nigral 
pathway, and the indirect striato-pallidal pathway which communicates information to the 
basal ganglia output structures; the internal segment of the globus pallidus and the 
substantia nigra pars reticulata (Smith, Y. & Kieval 2000; Gerfen & Wilson 1996). Although 
the two neuron subpopulations are GABAergic, they differ in a number of properties 
including the expression of different complements of dopamine, Adenosine, NMDA and 
acetylcholine receptor subtypes as well as of peptide content; the direct striato-nigral 
pathway neurons coexpress substance P and dynorphin, whereas the indirect striato-
pallidal pathway neurons express enkephalin (Gerfen et al., 1990, 1991; Reiner & Anderson 
1990; Gerfen & Wilson 1996; Le Moine & Bloch, 1995). 
Based on the fact that striatal medium-spiny neurons are the major input targets and the 
major projection neurons of striatum, it is thought that integration of neurotransmission in 
these neurons is an important determinant of the functional organization of the striatum. 
Thus, changes in neurotransmission on striatal spiny projection neurons have been involved 
in the regulation of voluntary movement, behavioral control, cognitive function and reward 
mechanisms. For instance, massive spiny projection neuron loss and major dopamine 
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deficits in striatum lead to severe motor disorders, such as the excess of involuntary 
movements encountered in Huntington’s disease and the rigidity and poverty of 
movements that typifies Parkinson’s disease, respectively (Ross et al., 1997; Wolfgang & 
Stanley, 2003). Therefore, investigations addressed to characterize new receptor proteins 
displaying high densities and potential involvement in neurotransmission mechanisms 
within the striatum can provide new insight into the basal ganglia physiology and 
pathophysiology and also new clues for therapy of severe motor disorders. 
A previous study reported a novel striatum-specific transcript, the strg/Gpr88, encoding an 
orphan G protein-coupled receptor of human and rodents (Mizushima et al., 2000). It display 
highest sequence homology with 5HT1D and β3 receptors. Since the original description, little 
data have been documented on the biological function (s) and the the cellular and subcellular 
distribution of the Gpr88 protein. Hence, the Gpr88 endogenous putative ligand, the detailed 
Gpr88 protein distribution and GPR88 functional roles are unknown. One approach to gain 
functional insights into this novel gene coding for an orphan receptor is the precise analysis of 
its spatial and temporal expression to provide information about the neural morphological 
substrates supporting Gpr88 functions in the striatal complex.  
Hence, the present findings provide in situ hybridization and light-level immunohistochemical 
evidence for Gpr88 localization in the rat and monkey striatum and its subcellular distribution 
in striatal neurons by using a validated polyclonal antibody specifically recognizing Gpr88, 
(Massart et al 2009). We also describe morphological data on the spatiotemporal Gpr88 
expression in the developing rat striatum, suggesting that both nigrostriatal and corticostriatal 
pathways control its normal striatal pattern of expression. Using treatments with l-DOPA and 
dopamine antagonists, in unilateral 6-hydroxydopamine- and cortical ibotenate-lesioned rats, 
we further demonstrated that striatal Gpr88 expression is modulated by dopamine- and 
glutamate-regulated mechanisms involving trans-synaptic influences of the corticostriatal 
pathway input activity. 
2. Widespread Gpr88 expression within the striatal complex  
Using in situ hybridization and immunohistochemistry approaches, we demonstrated that 
Gpr88 mRNA and protein expression are specially abundant within restricted basal 
telencephalic structures including the dorsal striatum, nucleus accumbens, and olfactory 
tubercle and also in the inferior olivary complex (Fig. 1). 
2.1 All striatal GABAergic spiny projection neurons express Gpr88 
Gpr88 is expressed throughout the two anatomical and functional patch/striosome-matrix 
compartments in the rat and monkey striatal complex (Figures 1F, 2A) with higher receptor 
expression in patch/striosome than in the surrounding matrix compartment. The prevalence 
of Gpr88 in the patch/striosome compartment and also within the dorsolateral striatal 
sector, indicates that Gpr88 may play a central role in the modulation of both limbic and 
motor cortical-basal ganglia circuits (Ragsdale & Graybiel; 1988; Graybiel A.M., 1995; Gerfen 
& Wilson, 1996). Immunofluorescent stainings and double labelling in situ hybridization 
experiments demonstrated that Gpr88 is present in all the spiny projection neurons of 
both the direct striato-nigral pathway and the indirect striato-pallidal pathway (Figure 2 
C,D).  
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Fig. 1. Gpr88 distribution in the rat and the monkey brains. Both Gpr88 mRNA (A,C) and 
Gpr88 protein (B,D,E,F) are particularly concentrated throughout the striatum (St), nucleus 
accumbens (Acb), olfactory tubercle (Tu) and the inferior olive complex (IO) of the rat (A-E). 
Similar levels and distribution-pattern of Gpr88 immunorreactivity is detected in nucleus 
caudatus (C), putamen (Pu) and nucleus accumbens (Acb) of the monkey brain (F). 
Significant levels of Gpr88 are also present with a laminar distribution throughout the 
neocortex. Arrows in (F), point out small and intense Gpr88 stained areas corresponding to 
striosome striatal subcompartments. RT-QPCR data from rodents suggest that Gpr88 
displays the highest expression levels compared to other known GPCRs of the striatum 
(Massart et al., 2007, 2008). The pattern of Gpr88 throughout the striatum of adult rats and 
monkeys is characterized by widespread distribution and regional differences (Figure 1), 
suggesting a central role of this orphan receptor in the modulation of sensorimotor related 
informations (Flaherty & Graybiel1994; Voorn et al., 2004). Although Gpr88 is prevalent in 
the striatal complex, we also detected moderate levels of both Gpr88 transcripts and protein 
throughout the cerebral neocortex (Figure 1A,B). Both signals display a similar non-
homogeneous laminar distribution characterized by higher expression in the upper 
neocortical layers II-IV than in the lower layers V-VI. No Gpr88 expression was detected in 
the cortical layer I. Moreover, cortical Gpr88 expression represents about 20% of the GPR88 
striatal expression, as assessed by different quantitive approaches including Western blot, 
immunohistochemistry and in situ hybridization. Double immuno-fluorescent labellings for 
Gpr88 and different neural cell-type specific markers have demonstrated that Gpr88 is an 
exclusive neuronal receptor of the brain, being absent from glial cells (Massart et al., 2009). 
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Fig. 2. Gpr88 distribution in the rat dorsal striatum. (A) The immunofluorescent Gpr88 
signal is heterogeneously distributed within the dorsal striatum and characterized by its 
marked concentration in the striatal dorsolateral region and the patches compartments. The 
inset illustrates putative medium spiny neurons displaying intense Gpr88 labelling on the 
cell surface along the soma and dendrites. (C, D) double-labelling in situ hybridization 
indicates that all Substance P (dark-stained cells in C) and enkephalin (dark-stained cells in 
D) neurons, also express Gpr88 transcripts (detected by silver grain labellings). The 
distribution of the electron-dense immunoreactive reaction product, reflects the subcellular 
GPR88 presence in submembranous sites around the perikaryon (arrow-heads in B asterisk 
and arrows in E). The receptor is concentrated in symmetrical synapses in the cell body 
(asterisk in E) but also in asymmetrical synapses (asterisk in F) in dendritic spines (Sp). Note 
the absence of immunolabelling in synaptic contacts of two adjacent nerve terminals (t) in E. 
(Enk) Enkephalin, (Nu) Cell nucleus, (So) neuronal cell body, (Sp) Substance P in C, (Sp) 
dendritic spine in F. 
Electron microscopic analysis of the Gpr88 immunolabelling in the rat dorsal striatum 
demonstrated a high proportion of electron dense Gpr88 positive dendritic spines, dendrite 
shafts and cell bodies (Figure 2 B,E,F) that are characteristic features of GABAergic spiny 
projection neurons (Somogyi et al., 1982; Bolam et al., 1983). However, no axonal or terminal 
Gpr88 immunolabeled profiles were observed. Likewise, globus pallidus and substantia nigra 
pars reticulata, two basal ganglia regions receiving the striato-pallidal and striato-nigral 
terminals respectively (Surmeier et al., 2007), lack Gpr88 immunoreactivity. All these 
morphological findings highlight a potential functional role for Gpr88 in synaptic events 
occurring on somatodendritic compartments and their integration in striato-nigral and striato-
pallidal medium spiny neurons. Gpr88 immunoreactivity was often concentrated on discrete 
postsynaptic sub-membranous sites in a large proportion of asymmetrical (excitatory) 
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synapses that generally receive glutamate as neurotransmitter (Bouyer et al., 1984; Bolam et al., 
2000) and also on symmetrical (inhibitory) synapses which could be supplied by terminals 
originating from GABAergic aspiny or cholinergic interneurons or even by intrastriatal 
GABAergic axon-collaterals from medium-spiny projection neurons. Double 
immunofluorescent labellings in the same section demonstrated no association between Gpr88 
immunoreactivity and tyrosine hydroxylase immunolabelled axon-terminals. In contrast, the 
Gpr88 immunoreactive signal was often juxtaposed to most vesicular glutamate transporter1 
immunoreactive terminals, indicating that Gpr88 is preferentially located on synapses 
supplied by cortical inputs, rather than by vesicular glutamate transporter2 immunoreactive 
thalamic inputs contacting medium spiny neurons (Herzog et al., 2001; Kaneko & Fujiyama, 
2002; Fremeau et al., 2004). Moreover, electron microscopy analysis demonstrates that Gpr88 
immunoreactive signal is often present on the head of spines, where corticostriatal inputs 
mainly contact the dendritic tree of striatal spiny projection neurons (Bouyer et al., 1984; Dube 
et al., 1988; Ribak & Roberts 1990; Smith et al., 1994). 
The preferential subcellular distribution of Gpr88 in striatal asymmetrical synapses of 
virtually all GABAergic projection neurons suggests a role for Gpr88 in the modulation of 
medium spiny neurons activity to cortical glutamatergic inputs and a potential role in the 
regulation of the flow of cortical information through the basal ganglia. Several lines of 
evidence indicate that cortical excitatory signals are modulated by dopaminergic synaptic 
contacts located on the neck of spines (Arbuthnott et al., 2000). Gpr88 location at specific 
synaptic sites, where corticostriatal and nigrostriatal afferents converge, further suggests 
involvement of Gpr88 in the modulation of both glutamatergic and dopaminergic signals 
received by the striatal medium spiny neurons.  
3. Spatial and temporal Gpr88 expression in the developing rat striatum 
To gain functional insights into striatal Gpr88 we have determined the profile of GPR88 
expression in the prenatal and postnatal developing striatum of the rat by in situ 
hybridization and immunohistochemistry. Morphological data indicate that Gpr88 
expression emerges with a homogeneous distribution, in the ventrolateral portion of the 
developing striatum at the embryonic day 16 (E16) of rat development (Figure 3A,B,C), a 
time when striatal neurons are both morphologically and functionally immature (van der 
Kooy & Fishell, 1987) and also when the patch-matrix striatal compartments, are not yet 
differentiated. The homogeneous Gpr88 mRNA distribution becomes heterogeneous when 
clusters of developing neurons displaying dense Gpr88 expression are seen throughout the 
dorsal and ventral striatal regions by the fetal stage E19-E20 (Figures 3D,E). Using double 
immunohistochemistry stained brain sections for Gpr88 and tyrosine hydroxylase, we 
confirmed that rich Gpr88 small areas strictly match the densely dopamine innervated 
striatal patch/striosome compartments (Gerfen et al., 1987). Levels of Gpr88 expression in 
patches compartments increase until the end of the first postnatal week and then decline in 
the second postnatal week with the ongoing development to eventually reach adult 
expression levels. Such developmental profile of Gpr88 expression in the prenatal and 
postnatal rat striatum suggests that the pattern of Gpr88 expression may be under the 
influence of afferent inputs reaching to the striatal primordia. This idea is based on the fact 
that the patchy-pattern profile of intense GPR88 expression in developing rat striatum 
closely matches the reported spatial and temporal development of the nigrostriatal 
dopamine afferents (Voorn et al., 1988), suggesting that the nigral dopamine inputs 
influence the patterning of striatal GPR88 expression. Such type of influence by the 
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dopamine inputs has been demonstrated for the establishment of the pattern of opiate 
receptors expression in the embryonic patch compartment (van der Kooy & Fishell, 1992). 
The cortical projections are the second major afferent input to the striatum that may act in 
concert with nigral dopamine inputs to guide development of striatal subcompartment 
phenotypes. For instance, studies in the monkey have shown the patchy distribution of 
corticostriatal afferents before the day of birth (Goldman-Rakic, 1981). Moreover, 
organotypic assays involving co-cultures of the striatum with substantia nigra or cortex 
indicate that afferents from these structures have a prominent influence on the development 
of striatal patch/matrix compartments (Snyder-Keller & Costantini 1996; Snyder-Keller et 
al., 2001; Snyder-Keller, 2004). The mutual influence of dopaminergic and glutamatergic 
pathways within the developing striatum is probably important for the setting up of striatal 
neurotransmission circuits, as previously shown by dopamine manipulations that influence 
corticostriatal synaptic configurations (Meshul & Tan, 1994; Meshul et al., 1999; Meshul & 
Allen, 2000; Avila-Costa et al., 2005). These observations support the idea that cortical 
glutamatergic inputs and/or dopamine glutamate interactions may exert a control on Gpr88 
expression in the developing medium spiny neurons. 
 
 
Fig. 3. Developmental profile of Gpr88 expression in the rat striatum. Gpr88 mRNA (A, D) 
and Gpr88-protein (E) expression in the developing striatum. (A) Homogeneous distribution 
of Gpr88 transcripts in the dorsolateral sector of differentiating striatum at E16. (D) 
Heterogeneous distribution of Gpr88-mRNA at E19. (F) Clusters of striatal developing 
neurons displaying dense Gpr88 immunoreactive signal (Gpr88-rich patches) at E20. (Cx) 
cortex, (St) striatum, (Tu) olfactory tubercle. 
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Although dopamine and glutamate afferents are the most likely candidates to modulate 
Gpr88 expression in developing medium-spiny projection neurons, other factors associated 
with nigral and cortical inputs may also play an important role in controlling Gpr88 
expression within the striatal primordium. For instance, the nigrostriatal and corticostriatal 
pathways supply the striatum with brain-derived neurotrophic factor (BDNF) (Altar et al., 
1997; Seroogy et al., 1994) which has been shown to influence survival, sprouting, and 
synaptogenesis in different neural systems (Hammond et al., 1999; Alsina et al., 2001; 
Mamounas et al., 2000). Moreover, studies in mature animals have shown that BDNF has 
profound effects on neurotransmission, activity-dependent synaptic remodeling, 
neurogenesis and receptors expression (Altar et al., 1997; Lessmann, 1998; Guillin et al., 
2001; Tanaka et al., 2008; Taliaz, 2010). Rather than exclusive effects of either dopamine or 
glutamate on striatal Gpr88, continuous interplay among afferent signaling systems, 
including dopamine, glutamate and BDNF, is likely to refine the pattern expression of 
Gpr88 throughout the period of striatal development. Based on the spatiotemporal profile of 
GPR88 expression during striatal differentiation, we propose that the early receptor 
expression is modulated at least in part through a nigrostriatal and corticostriatal pathway 
dependent mechanisms. In support to the hypothesis of BDNF regulating Gpr88 expression 
during development, heterozygote BDNF-knockout mice have diminished Gpr88 mRNA 
levels in both the caude putamen and the shell of the nucleus accumbens (Massart et al., 
2005). 
4. Modulation of striatal Gpr88 expression by nigrostriatal and corticostriatal 
pathways in the rat in a model of Parkinson’s disease 
The demonstration of the regulation of striatal Gpr88 expression by nigrostriatal dopamine 
and cortical glutamate inputs was carried out in a rat model of Parkinson’s disease 
(Schwarting & Huston 1996; Massart et al., 2009). Unilateral lesion of dopamine nigrostriatal 
pathway, caused by infusion of 6-OHDA in the medial forebrain bundle, produced a 
decrease in Gpr88 protein and mRNA expressions (Table 1). However, in situ hybridization 
analysis with double labelling showed that the effects of dopamine depletion were different 
in the two subpopulations of striatal medium spiny neurons. At the cellular level, 6-OHDA 
lesion induced a decrease in mRNA expression in striato-pallidal pathway neurons and 
inversely, a rise in striato-nigral projection neurons, in the dopamine depleted striatum 
(Table 1). Recently reported data (Heiman et al., 2008; Massart et al., 2009) showed that 
striatal Gpr88 mRNA expression is twice as high in striato-pallidal output neurons as in 
striato-nigral output neurons of rodents, the overall lesion-induced Gpr88 downregulation 
is consistent with the strong decrease in Gpr88 expression occurring in striato-pallidal 
pathway neurons, not compensated by the limited increase occurring in striato-nigral 
pathway neurons. These opposed variations are nearly completely reversed by a typical 
antiparkinsonian treatment with l-DOPA (Table 1). 
Our finding revealed that D1 receptors, but not D2 receptors, activation exerts a positive 
influence on Gpr88 expression in the indirect striato-pallidal pathway of the dopamine-
depleted hemisphere. On the contrary, D2 receptors stimulation controls Gpr88 expression 
in the direct striato-nigral pathway. This is rather surprising since D1 and D2 receptors are 
largely segregated to striatal neurons of the striato-nigral and striato-pallidal pathways, 
respectively (Gerfen et al., 1990; Le Moine & Bloch, 1995). In fact, in striato-pallidal medium 
spiny neurons harboring D2 receptors/Enk, in contrast to striato-nigral medium spiny 
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Treatment
 
Gpr88 protein – 
immunohistochemistry
Gpr88 mRNA - In situ hybridization 
Total mRNA mRNA / SP+  
cells 
mRNA / ENK+ 
cells 
Intact Lesioned Intact Lesioned Intact Lesioned Intact Lesioned 
 
 
6-OHDA 
lesion 
Vehicle 
107 ± 3.8 91 ± 2.9 * 69 ± 3.2 56 ± 1.4 * 22 ± 1.4 
29 ± 1.9 
*** 
42 ± 2.1 
31 ± 1.8 
*** 
L- DOPA 
 
99 ± 5.1 90 ± 4.6 73 ± 4.2 70 ± 3.7 22 ± 1.4 26 ± 1.7 40 ± 0.8 38 ± 1.3 
L-DOPA + 
SCH23390
108 ± 5.9 92 ± 5.6 76 ± 6.8 62 ± 3.2 23 ± 2.7 21 ± 1.6 43 ± 3.3 
26 ± 4.3 
*** 
L-DOPA + 
Haloperidol
100 ± 5.5 92 ± 6.1 74 ± 4.4 75 ± 3.0 37 ± 1.9 *** 26 ± 0.9 40 ± 1.4 39 ± 1.1 
lbotenate 
lesion 
Vehicle 
107 ± 3 83 ± 3 *** 89 ± 3.8
78 ± 1.9 
*** 
19 ± 0.5 17 ± 0.5 32 ± 0.9 
23 ± 1.2 
*** 
Table 1. Effects on Gpr88 expression of dopamine depletion, induced by unilateral 6-OHDA 
infusion into the medial forebrain bundle, or of a bilateral lesion of the cortex induced by 
multiple infusions of ibotenate. All data are expressed as group mean ±SEM. The raw data 
for 6-OHDA (nigro-striatal) lesion were analysed by two-way ANOVA with lesion and 
treatment as independent variable and the Bonferroni test for multiple comparisons was 
applied in post hoc analysis to determine which values were significantly different. For data 
from ibotenate-induced lesion, the Student’s unpaired two-tailed t-test was used to compare 
Ibotenate-injected vs. vehicle-injected rats. Alpha level level was set at 0.05. GraphPad 5 
software (La Jolla, California, USA) was used to perform statistical analysis . * P < 0.05; **P 
< 0.01; ***P < 0.001 vs. intact side (6-OHDA lesion) or intact, vehicle-infused animals 
(ibotenate lesion). See Massart et al. 2009 for details. 
neurons containing D1 receptors/Sp, Gpr88 expression was downregulated by the 6-OHDA 
lesion and the reversion of this effect by l-DOPA was dependent on D1 receptor stimulation, 
as indicated by its blockade by the D1 receptor-selective antagonist SCH23390, but not by 
haloperidol, a D2 receptor-selective antagonist (Table 1). In parallel, in D1 receptor/Sp-
expressing striato-nigral neurons, Gpr88 expression was upregulated by the lesion, in 
contrast to D2 receptor/Enk striato-pallidal output neurons. The reversion of this effect by l-
DOPA was dependent of D2 receptors stimulation, as indicated by the absence of effects of 
SCH23390 (Table 1). Moreover, co-administration of l-DOPA and D2-receptor antagonist 
haloperidol raised Gpr88 expression in striato-nigral medium spiny neurons of the 
contralateral hemisphere (See Massart et al 2009; Taymans., 2005).  
These results suggest that l-DOPA effects on Gpr88, in each of the two medium spiny 
neuron subsets, are not directly mediated by the respective dopamine receptor subtypes 
they express, but indirectly by dopamine receptor transmission through a different 
neurotransmitter afferent input to the medium spiny neurons. In particular l-DOPA and 
intrastriatal dopamine transmission can act as a neuromodulator of glutamate release in the 
dopamine depleted striatum (Jonkers et al., 2002; David et al., 2005; Stephens 2005). l-DOPA 
effects on Gpr88 expression in striato-pallidal pathway neurons are likely regulated through 
D1 receptor present on the soma and dendrites of excitatory corticostriatal projection 
neurons, leading to activation of the corticostriatal inputs. In contrast, l-DOPA/D2 receptors 
stimulation-induced Gpr88 decrease in striato-nigral neurons was probably mediated by 
reduced glutamate release from corticostriatal inputs by stimulation of presynaptic D2 
receptors (Cepeda et al., 2001). Thus, l-DOPA-induced differential changes in Gpr88 levels 
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on both striato-nigral and striato-pallidal medium spiny neurons, may be mediated through 
dopamine-induced influences in corticostriatal glutamatergic neurotransmission 
mechanisms, as previously suggested for the modulation of other striatal markers expressed 
in these neurons (Uhl et al., 1988; Salin et al., 1997; Zeng et al., 2000; Blandini et al., 2003; 
Robelet et al 2004; Carta et al., 2005).  
In support to the above hypothesis, corticostriatal deafferentation, elicited by ibotenate 
infusions, induced a marked Gpr88 mRNA and protein down-regulation in striato-pallidal 
neurons without significantly affecting Gpr88 in striato-nigral neurons (Table 1). These data 
agree with the involvement of corticostriatal glutamatergic input in the effects of dopamine 
depletion induced Gpr88 changes in the striatal medium spiny projections neurons, and 
with a greater influence of cortical inputs on Gpr88 expression in the striato-pallidal 
pathway neurons. 
5. Conclusions 
Gpr88 is an important constituent of the basal ganglia, being one of the most abundant 
GPCR in this brain region. Although its function is unknown, detailed analysis of its gene 
expression in striatal spiny projection neurons suggests that Gpr88 has typical features of a 
GPCR in charge of transducing extracellular signals. First, it is expressed at the plasma 
membrane of striatal medium-spiny projection neurons, and probably exposed to the 
extracellular signals. Second, establishment of Gpr88 expression during development is 
concomitant with major dopaminergic and glutamatergic afferences reaching the embryonic 
striatum. Third, Gpr88 expression is enriched in the patch/striosome compartment, which 
suggests its involvement in the modulation of both limbic and motor cortical-basal ganglia 
circuits. Fourth, Gpr88 expression is influenced by modifications of cortical and nigral 
inputs to medium spiny neurons occurring in a situation modeling the pronounced loss of 
dopamine-producing neurons, occurring in Parkinson’s disease.  
Striato-nigral and striato-pallidal pathways neurons play an important role in integrating 
circuits of the basal ganglia/basal forebrain and finding on new proteins in these two major 
striatal output pathways, may contribute to a better understanding of certain 
pathophysiologic states (e.g., movement and psychiatric disorders). Hence, the rich and 
selective expression of GPR88 in the two striatal subpopulations medium-spiny projection 
neurons, directly receiving dopaminergic and glutamatergic inputs provides an anatomical 
basis for potential therapeutic applications, particularly in the striatum where modulation of 
glutamatergic and dopaminergic functions have important consequences for Parkinson’s 
disease and its treatment. 
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in elucidating important aspects of the disease, such as selective vulnerability of substantia nigra dopaminergic
neurons to the degenerative process.
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